Latest filing published 02 Mar 2026 for AbCellera Biologics Inc., €111k. Read the official filing
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Thermopylae Holdings Ltd. is a declared insider of AbCellera Biologics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 9 June 2021 to 27 February 2026, the count stands at 17 filings.
Both buying and selling appear: 12 purchases worth €20.2M, against 1 sale worth €110.4M. The net balance comes to €90.2M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 2 purchases and no sales.
In size, the median ticket on the buying side is €746k. Of 12 purchases, 9 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 2 March 2026, reports an open-market purchase of €111k in AbCellera Biologics Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations